Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co LtdfiledCriticalHanmi Pharm Ind Co Ltd
Priority claimed from PCT/KR2017/006922external-prioritypatent/WO2018004283A2/ko
Publication of CR20190161ApublicationCriticalpatent/CR20190161A/es
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
La presente invención se refiere a un derivado de glucagon, un conjugado del mismo, y una composición que comprende el mismo, y un uso terapéutico del mismo, y en particular, para síndrome metabólico, hipoglucemia, e hiperinsulinismo congénito.
CR20190161A2016-12-292017-06-29Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terpéutico del mismo
CR20190161A
(es)
Antecedents of ]-n5,1-dimethyl3--oxo-(3,2-dihydro-h1-pyrazol-4-yl)]-methyl-isoxazole-3-carboxamide and pharmaceutical preparations including these antecedents